Journal article
The HealthNuts population-based study of paediatric food allergy: Validity, safety and acceptability
NJ Osborne, JJ Koplin, PE Martin, LC Gurrin, L Thiele, ML Tang, AL Ponsonby, SC Dharmage, KJ Allen
Clinical and Experimental Allergy | WILEY | Published : 2010
Abstract
Summary Background The incidence of hospital admissions for food allergy-related anaphylaxis in Australia has increased, in line with world-wide trends. However, a valid measure of food allergy prevalence and risk factor data from a population-based study is still lacking. Objective To describe the study design and methods used to recruit infants from a population for skin prick testing and oral food challenges, and the use of preliminary data to investigate the extent to which the study sample is representative of the target population. Methods The study sampling frame design comprises 12-month-old infants presenting for routine scheduled vaccination at immunization clinics in Melbourne, Au..
View full abstractGrants
Funding Acknowledgements
We would like to thank the additional HealthNuts team members Margaret Gibson, Kirsten Aurich, and the HealthNuts safety committee - Associate Professor Noel Cranswick (Australian Paediatric Pharmacology Research Unit/Murdoch Childrens Research Institute), Dr Jo Smart (Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia) and Associate Professor Jo Douglass (Head of Allergy, Alfred Hospital, Melbourne, Australia); and all the parents and children who participated in the study. Funding for this project was obtained from the National Health & Medical Research Council, Ilhan Food Allergy Foundation and Anaphylaxi-Stop. K. J. A. and L. C. G. hold National Health & Medical Research Council Career Development Awards. J. J. K. and P. E. M. are Australian Postgraduate Award scholars.